Low‐Dose Emicizumab Versus Low‐/Intermediate‐Dose Factor VIII Secondary Prophylaxis for Noninhibitor Haemophilia A Patients With Severe Bleeding Phenotype

Documenti analoghi

• HEAD‐US Score and Cartilage Biomarkers in Patients With Severe Haemophilia A Who Receive Low‐Dose Factor VIII Prophylaxis
  di: Arpanan Pramualratthakarn, et al.
  Pubblicazione: (2026)
• Reduced‐Dose versus Standard‐Dose Emicizumab for Haemophilia A: A Retrospective Cohort Study
  di: Huiling Yan, et al.
  Pubblicazione: (2025)
• Dental Management of Persons With Haemophilia Receiving Emicizumab Prophylaxis
  di: Branislav V. Bajkin, et al.
  Pubblicazione: (2026)
• A Global Cross‐Sectional Database Study of Low Dose FVIII SHL Prophylaxis in Haemophilia A
  di: Dagmar M. Hajducek, et al.
  Pubblicazione: (2025)
• Multicentre Retrospective and Prospective Analysis of Data on Emicizumab and Factor VIII Prophylaxis in Children With Severe Haemophilia A: Egypt‐Compare Study
  di: Tamer Hassan, et al.
  Pubblicazione: (2026)